A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma

被引:2
|
作者
Zhang, Hai-Feng [1 ,2 ]
Delaidelli, Alberto [1 ,2 ]
Javed, Sumreen [3 ]
Turgu, Busra [1 ,2 ]
Morrison, Taylor [2 ]
Hughes, Christopher S. [1 ,2 ]
Yang, Xiaqiu [2 ]
Pachva, Manideep [1 ,2 ]
Lizardo, Michael M. [1 ,2 ]
Singh, Gurdeep [2 ]
Hoffmann, Jennifer [4 ,5 ]
Huang, Yue Zhou [2 ]
Patel, Khushbu [4 ,5 ,6 ]
Shraim, Rawan [4 ,5 ,7 ]
Kung, Sonia H. Y. [8 ]
Morin, Gregg B. [9 ,10 ]
Aparicio, Samuel [1 ,2 ]
Martinez, Daniel [4 ,5 ,6 ]
Maris, John M. [4 ,5 ,6 ]
Bosse, Kristopher R. [4 ,5 ,6 ]
Williams, Karla C. [3 ]
Sorensen, Poul H. [1 ,2 ]
机构
[1] Univ British Columbia, Dept Pathol & Lab Med, 2211 Wesbrook Mall, Vancouver, BC V6T 1Z4, Canada
[2] BC Canc Agcy, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada
[3] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[4] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[5] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA
[6] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[7] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA
[8] Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada
[9] Canadas Michael Smith Genome Sci Ctr, Vancouver V5Z 4S6, BC, Canada
[10] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T1Z4, Canada
基金
加拿大健康研究院;
关键词
MIGRATION INHIBITORY FACTOR; DEAD BOX GENE; PLEIOTROPIC ROLE; GREB1; MEDULLOBLASTOMA; COAMPLIFICATION; EXPRESSION; MORPHOLOGY; REGULATOR; PROTEINS;
D O I
10.1126/sciadv.adg6693
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MYCN amplification (MNA) is a defining feature of high-risk neuroblastoma (NB) and predicts poor prognosis. However, whether genes within or in close proximity to the MYCN amplicon also contribute to MNA(+) NB remains poorly understood. Here, we identify that GREB1, a transcription factor encoding gene neighboring the MYCN locus, is frequently coexpressed with MYCN and promotes cell survival in MNA(+) NB. GREB1 controls gene expression independently of MYCN, among which we uncover myosin 1B (MYO1B) as being highly expressed in MNA(+) NB and, using a chick chorioallantoic membrane (CAM) model, as a crucial regulator of invasion and metastasis. Global secretome and proteome profiling further delineates MYO1B in regulating secretome reprogramming in MNA(+) NB cells, and the cytokine MIF as an important pro-invasive and pro-metastatic mediator of MYO1B activity. Together, we have identified a putative GREB1-MYO1B-MIF axis as an unconventional mechanism promoting aggressive behavior in MNA(+) NB and independently of MYCN.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma
    Zhang, Hai-Feng
    Delaidelli, Alberto
    Javed, Sumreen
    Turgu, Busra
    Hughes, Christopher S.
    Yang, Xiaqiu
    Lizardo, Michael
    Martinez, Daniel
    Maris, John M.
    Bosse, Kristopher R.
    Williams, Karla C.
    Sorensen, Poul H.
    CANCER RESEARCH, 2023, 83 (07)
  • [2] A MYCN-INDEPENDENT MECHANISM MEDIATING SECRETOME REPROGRAMMING AND METASTASIS IN MYCN-AMPLIFIED NEUROBLASTOMA
    Zhang, Hai-Feng
    Delaidelli, Alberto
    Javed, Sumreen
    Turgu, Busra
    Yang, Xiaqiu
    Lizardo, Michael
    Martinez, Daniel
    Maris, John
    Bosse, Kristopher
    Williams, Karla
    Sorensen, Poul
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S67 - S68
  • [3] Locoregional MYCN-amplified neuroblastoma
    La Madrid, Andres Morales
    Volchenboum, Samuel
    Gastier-Foster, Julie M.
    Pyatt, Robert
    Liu, Don
    Pytel, Peter
    Lavarino, Cinzia
    Rodriguez, Eva
    Cohn, Susan L.
    PEDIATRIC BLOOD & CANCER, 2012, 59 (04) : 736 - 738
  • [4] MYCN PARTICIPATES IN A REGULATORY MIRNA NETWORK IN MYCN-AMPLIFIED NEUROBLASTOMA
    Flaegstad, Trond
    Buchner, Jochen
    Henriksen, Jorn
    Lokke, Cecilie
    Tomte, Ellen
    Haug, Bjorn Helge
    Einvik, Christer
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 807 - 807
  • [5] Epigenetic Dysregulation in MYCN-Amplified Neuroblastoma
    Epp, Soraya
    Chuah, Shin Mei
    Halasz, Melinda
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (23)
  • [6] The MicroRNA Landscape of MYCN-Amplified Neuroblastoma
    Misiak, Danny
    Hagemann, Sven
    Bell, Jessica L.
    Busch, Bianca
    Lederer, Marcell
    Bley, Nadine
    Schulte, Johannes H.
    Huttelmaier, Stefan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] Metabolic reprogramming of MYCN amplified neuroblastoma
    Morrison, Monique
    Khuu, Scott
    Schiffman, Joshua
    Cairns, Bradley
    Rutter, Jared
    Winge, Dennis
    Spelennan, Frank
    Stewart, Rodney
    MOLECULAR CANCER RESEARCH, 2015, 13
  • [8] Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma
    Hungate, Eric A.
    Applebaum, Mark A.
    Skol, Andrew D.
    Vaksman, Zalman
    Diamond, Maura
    McDaniel, Lee
    Volchenboum, Samuel L.
    Stranger, Barbara E.
    Maris, John M.
    Diskin, Sharon J.
    Onel, Kenan
    Cohn, Susan L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (10):
  • [9] CAMKV as an immunotherapy target in MYCN-amplified neuroblastoma
    Sussman, Robyn T.
    Huang, Kevin
    Raman, Pichai
    Maris, John M.
    CANCER RESEARCH, 2015, 75
  • [10] MYCN upregulates the transsulfuration pathway to suppress the ferroptotic vulnerability in MYCN-amplified neuroblastoma
    Floros, Konstantinos, V
    Chawla, Ayesha T.
    Johnson-Berro, Mia O.
    Khatri, Rishabh
    Stamatouli, Angeliki M.
    Boikos, Sosipatros A.
    Dozmorov, Mikhail G.
    Cowart, L. Ashley
    Faber, Anthony C.
    CELL STRESS, 2022, 6 (02) : 21 - 29